1. Singh Malhotra, H, Gupta, P, Prabhu, V, et al. COVID-19 vaccination-associated myelitis. QJM. Epub ahead of print 31 March 2021. DOI: 10.1093/qjmed/hcab069.
Google Scholar | Crossref2. Pagenkopf, C, Sudmeyer, M. A case of longitudinally extensive transverse myelitis following vaccination against Covid-19. J Neuroimmunol 2021; 358: 577606.
Google Scholar | Crossref | Medline3. Hemmer, B, Borsanyi, C. Diagnose und Therapie der Multiplen Sklerose, Neuromyelitis-optica-SpektrumErkrankungen und MOG-IgG-assoziierten Erkrankungen, S2k-Leitlinie. Leitlinien für Diagnostik und Therapie in der Neurologie, 2021, www.dgn.org/leitlinien
Google Scholar4. Voysey, M, Clemens, SAC, Madhi, SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 2021; 397: 99–111.
Google Scholar | Crossref | Medline5. Vegezzi, E, Ravaglia, S, Buongarzone, G, et al. Acute myelitis and ChAdOx1 nCoV-19 vaccine: Casual or causal association? J Neuroimmunol 2021; 359: 577686.
Google Scholar | Crossref | Medline6. Roman, GC, Gracia, F, Torres, A, et al. Acute transverse myelitis (ATM): Clinical review of 43 patients with COVID-19-associated ATM and 3 post-vaccination ATM serious adverse events with the ChAdOx1 nCoV-19 vaccine (AZD1222). Front Immunol 2021; 12: 653786.
Google Scholar | Crossref | Medline7. Sriwastava, S, Tandon, M, Podury, S, et al. COVID-19 and neuroinflammation: A literature review of relevant neuroimaging and CSF markers in central nervous system inflammatory disorders from SARS-COV2. J Neurol. Epub ahead of print 19 May 2021. DOI: 10.1007/s00415-021-10611-9.
Google Scholar | Crossref8. Jumah, M, Rahman, F, Figgie, M, et al. COVID-19, HHV6 and MOG antibody: A perfect storm. J Neuroimmunol 2021; 353: 577521.
Google Scholar | Crossref | Medline9. Sinha, R, Wander, A, Kapoor, A, et al. Acute demyelinating syndrome (MOG antibody positive) associated with COVID-19 infection: A widening spectrum. Clin Pediatr 2021; 60: 501–503.
Google Scholar | SAGE Journals10. Kogure, C, Kikushima, W, Fukuda, Y, et al. Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in a COVID-19 patient: A case report. Medicine 2021; 100: e25865.
Google Scholar | Crossref | Medline11. Zoric, L, Rajovic-Mrkic, I, Colak, E, et al. Optic neuritis in a patient with seropositive myelin oligodendrocyte glycoprotein antibody during the post-COVID-19 period. Int Med Case Rep J 2021; 14: 349–355.
Google Scholar | Crossref | Medline12. Peters, J, Alhasan, S, Vogels, CBF, et al. MOG-associated encephalitis following SARS-COV-2 infection. Mult Scler Relat Disord 2021; 50: 102857.
Google Scholar | Crossref | Medline13. Woodhall, M, Mitchell, JW, Gibbons, E, et al. Case report: Myelin oligodendrocyte glycoprotein antibody-associated relapse with COVID-19. Front Neurol 2020; 11: 598531.
Google Scholar | Crossref | Medline14. Garg, RK, Paliwal, VK, Gupta, A. Spinal cord involvement in COVID-19: A review. J Spinal Cord Med. Epub ahead of print 11 March 2021. DOI: 10.1080/10790268.2021.1888022.
Google Scholar | Crossref15. Amano, H, Miyamoto, N, Shimura, H, et al. Influenza-associated MOG antibody-positive longitudinally extensive transverse myelitis: A case report. BMC Neurol 2014; 14: 224.
Google Scholar | Crossref | Medline16. Loos, J, Pfeuffer, S, Pape, K, et al. MOG encephalomyelitis: Distinct clinical, MRI and CSF features in patients with longitudinal extensive transverse myelitis as first clinical presentation. J Neurol 2020; 267(6): 1632–1642.
Google Scholar | Crossref | Medline17. Jarius, S, Paul, F, Aktas, O, et al. MOG encephalomyelitis: International recommendations on diagnosis and antibody testing. J Neuroinflammation 2018; 15: 134.
Google Scholar | Crossref | Medline18. Whittam, DH, Cobo-Calvo, A, Lopez-Chiriboga, AS, et al. Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients. Mult Scler Relat Disord 2020; 44: 102251.
Google Scholar | Crossref | Medline